June 4, 2026

From Discovery to Development: Presenting Our Pipeline at the Knowledge for Growth

We are happy to share how we advance the next-generation multispecific antibodies through a unique "Retrofit" lab-in-the-loop reverse translation approach—combining multi-omics, spatial profiling, AI, and functional R&D to tackle immunotherapy-refractory tumors.

Linkedin

Share this article
News
Latest Updates
Research moves fast. These updates track where Retrofit's programs stand, from new preclinical data to platform milestones and conference presentations as we advance toward spin-off.
Contact
Let's connect.
Whether you are an investor exploring early-stage opportunities, a pharma company looking for strategic partnership or an academic group interested in future collaboration, we’d love to hear from you.
Address
KU Leuven · Herestraat 49 3000 Leuven, Belgium
Full name
Organization
Email
I am reaching out as
Message
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.